Endrisone

Endrisone (INN) (brand name Aldrisone), or endrysone (USAN), is a synthetic, steroidal glucocorticoid which is or has been marketed in Italy by SIFI.[1][2][3] It is used as a topical and ophthalmic anti-inflammatory drug in the treatment of skin and eye conditions, respectively.[1][2]

Endrisone
Clinical data
Trade namesAldrisone
Other namesDelta-medrysone;[1] 6α-Methyl-11β-hydroxypregna-1,4-diene-3,20-dione; 6α-Methyl-11β-hydroxy-Δ1-progesterone
Routes of
administration
Topical, ophthalmic[1][2]
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard100.047.587
Chemical and physical data
FormulaC22H30O3
Molar mass342.479 g/mol g·mol−1
3D model (JSmol)

See also

References

  1. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 486–. ISBN 978-1-4757-2085-3.
  2. I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 110–. ISBN 978-94-011-4439-1.
  3. Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 386–. ISBN 978-3-88763-075-1.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.